Carole Ho
Overview
Carole Ho received an average of $3M in total compensation, including $433K in salary, at Denali Therapeutics from 2016 to 2021.
Source: SEC filings on April 19, 2022, April 22, 2021, April 22, 2020, April 18, 2019, and April 26, 2018.
Related executives
We found three more executives who work or worked at Denali Therapeutics.
News
Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
April 19, 2022
Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
April 22, 2021
Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
April 22, 2020
Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
April 18, 2019